Clinical Trial Update: Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating usability of the MIND1 medical information device in adults with schizophrenia treated with aripiprazole; study completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• MIND1

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Mental Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-08-15